Group 1: Company Overview - Exact Sciences (EXAS) is a notable stock within the Medical sector, which consists of 960 companies and currently ranks 6 in the Zacks Sector Rank [2] - The company has a Zacks Rank of 1 (Strong Buy), indicating strong potential for outperforming the market in the near term [3] Group 2: Performance Metrics - Over the past 90 days, the Zacks Consensus Estimate for EXAS' full-year earnings has increased by 125%, reflecting improved analyst sentiment and earnings outlook [4] - Year-to-date, EXAS has returned approximately 2.6%, outperforming the Medical sector average return of 1.5% [4] Group 3: Industry Context - Exact Sciences is part of the Medical - Biomedical and Genetics industry, which includes 472 stocks and currently ranks 89 in the Zacks Industry Rank [6] - The average return for the Medical - Biomedical and Genetics industry so far this year is 8.1%, indicating that EXAS is slightly underperforming its industry [6] Group 4: Comparison with Peers - Another stock in the Medical sector, Adicet Bio, Inc. (ACET), has a year-to-date return of 4% and a Zacks Rank of 2 (Buy) [5] - The consensus estimate for Adicet Bio's current year EPS has increased by 2.4% over the past three months, showcasing its positive outlook [5]
Are Medical Stocks Lagging Exact Sciences (EXAS) This Year?